NYSE:OMI - Owens & Minor Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $50.33
  • Forecasted Upside: 46.11 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$34.45
▼ -0.15 (-0.43%)

This chart shows the closing price for OMI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Owens & Minor Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OMI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OMI

Analyst Price Target is $50.33
▲ +46.11% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Owens & Minor in the last 3 months. The average price target is $50.33, with a high forecast of $62.00 and a low forecast of $37.00. The average price target represents a 46.11% upside from the last price of $34.45.

This chart shows the closing price for OMI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 contributing investment analysts is to buy stock in Owens & Minor. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
2/17/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
5/18/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
8/16/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/14/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/12/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/13/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/12/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/11/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/4/2022Credit Suisse GroupLower Price TargetNeutral$43.00 ➝ $37.00Low
8/4/2022Robert W. BairdLower Price TargetOutperform$70.00 ➝ $62.00N/A
8/4/2022CitigroupLower Price Target$58.00 ➝ $52.00Low
5/16/2022CitigroupBoost Price TargetNA$58.00N/A
4/26/2022CitigroupInitiated CoverageBuyHigh
2/28/2022Credit Suisse GroupBoost Price TargetNeutral$42.00 ➝ $43.00Medium
12/17/2021CitigroupUpgradeNeutral ➝ Buy$55.00Low
8/4/2021Credit Suisse GroupLower Price TargetNeutral$43.00 ➝ $42.00High
5/27/2021Robert W. BairdBoost Price TargetBuy ➝ Outperform$52.00 ➝ $55.00Medium
5/27/2021CitigroupBoost Price TargetNeutral$39.00 ➝ $46.00Medium
5/11/2021Credit Suisse GroupBoost Price TargetNeutral$34.00 ➝ $38.00Medium
3/26/2021Robert W. BairdUpgradeOutperform$45.00 ➝ $50.00High
2/25/2021BarclaysBoost Price TargetEqual Weight$23.00 ➝ $33.00High
12/17/2020UBS GroupUpgradeNeutral ➝ Buy$27.00 ➝ $37.00Medium
12/11/2020Smith Barney CitigroupInitiated CoverageNeutral$30.00Low
11/5/2020UBS GroupBoost Price TargetNeutral$13.00 ➝ $27.00High
11/4/2020BarclaysBoost Price TargetEqual Weight$20.00 ➝ $23.00High
9/25/2020CSFBBoost Price TargetNeutral$18.00 ➝ $22.00Low
9/25/2020Credit Suisse GroupBoost Price TargetNeutral$18.00 ➝ $22.00Medium
9/25/2020BarclaysUpgradeUnderweight ➝ Equal Weight$20.00Low
9/24/2020Robert W. BairdBoost Price TargetOutperform$21.00 ➝ $34.00High
8/7/2020Credit Suisse GroupLower Price TargetNeutral$17.00 ➝ $16.00Low
7/22/2020BarclaysBoost Price TargetUnderweight$4.00 ➝ $10.00High
7/21/2020Robert W. BairdUpgradeNeutral ➝ Outperform$8.00 ➝ $14.00High
7/21/2020Bank of AmericaUpgradeNeutral ➝ Buy$8.00 ➝ $12.00High
6/10/2020CfraBoost Price TargetBuy$8.50 ➝ $9.50High
5/7/2020CfraLower Price TargetBuy$11.00 ➝ $8.50Low
5/5/2020Robert W. BairdDowngradeOutperform ➝ Neutral$8.00High
4/22/2020Credit Suisse GroupInitiated CoverageNeutral$8.00Low
3/30/2020CfraUpgradeHold ➝ Buy$5.50 ➝ $9.00High
1/21/2020Robert W. BairdUpgradeNeutral ➝ Outperform$9.00High
9/6/2019Bank of AmericaBoost Price TargetNeutral$4.00 ➝ $7.50Medium
4/10/2019Bank of AmericaReiterated RatingNeutral$7.00 ➝ $4.50High
2/21/2019BarclaysReiterated RatingSell$5.00Medium
2/21/2019Jefferies Financial GroupReiterated RatingHold$7.00Low
1/17/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$8.00High
1/6/2019BarclaysReiterated RatingSell$6.00Low
1/3/2019Bank of AmericaLower Price TargetNeutral ➝ Neutral$11.00 ➝ $7.00Medium
11/2/2018Jefferies Financial GroupReiterated RatingHold$8.50High
11/1/2018BarclaysReiterated RatingUnderweight ➝ Underweight$12.00 ➝ $8.00High
10/31/2018SVB LeerinkSet Price TargetHold$9.00High
10/31/2018Bank of AmericaDowngradeBuy ➝ NeutralHigh
3/8/2018BarclaysInitiated CoverageUnderweight ➝ Underweight$16.00Medium
2/27/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$19.00Low
2/15/2018JPMorgan Chase & Co.Lower Price TargetUnderweight ➝ Underweight$21.00 ➝ $20.00Low
12/19/2017JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Underweight$22.00High
11/20/2017Credit Suisse GroupReiterated RatingUnderperform$31.00 ➝ $17.00N/A
11/2/2017SVB LeerinkReiterated RatingMarket Perform$34.00 ➝ $23.00N/A
10/12/2017Robert W. BairdReiterated RatingHold$28.00N/A
9/1/2017Robert W. BairdUpgradeUnderperform ➝ Neutral$28.00Medium
(Data available from 8/12/2017 forward)

News Sentiment Rating

0.42 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/14/2022
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/13/2022
  • 5 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
3/15/2022
  • 9 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/14/2022
  • 8 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/14/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/13/2022
  • 4 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/13/2022
  • 4 very positive mentions
  • 10 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
8/12/2022

Current Sentiment

  • 4 very positive mentions
  • 10 positive mentions
  • 5 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Owens & Minor logo
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.
Read More

Today's Range

Now: $34.45
Low: $34.32
High: $35.48

50 Day Range

MA: $32.94
Low: $29.71
High: $36.64

52 Week Range

Now: $34.45
Low: $29.50
High: $49.11

Volume

477,872 shs

Average Volume

782,341 shs

Market Capitalization

$2.63 billion

P/E Ratio

17.05

Dividend Yield

N/A

Beta

0.55

Frequently Asked Questions

What sell-side analysts currently cover shares of Owens & Minor?

The following Wall Street analysts have issued research reports on Owens & Minor in the last twelve months: Citigroup Inc., Credit Suisse Group AG, Robert W. Baird, StockNews.com, and TheStreet.
View the latest analyst ratings for OMI.

What is the current price target for Owens & Minor?

3 Wall Street analysts have set twelve-month price targets for Owens & Minor in the last year. Their average twelve-month price target is $50.33, suggesting a possible upside of 46.1%. Robert W. Baird has the highest price target set, predicting OMI will reach $62.00 in the next twelve months. Credit Suisse Group AG has the lowest price target set, forecasting a price of $37.00 for Owens & Minor in the next year.
View the latest price targets for OMI.

What is the current consensus analyst rating for Owens & Minor?

Owens & Minor currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OMI will outperform the market and that investors should add to their positions of Owens & Minor.
View the latest ratings for OMI.

What other companies compete with Owens & Minor?

How do I contact Owens & Minor's investor relations team?

Owens & Minor's physical mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. The company's listed phone number is (804) 723-7000 and its investor relations email address is [email protected] The official website for Owens & Minor is www.owens-minor.com. Learn More about contacing Owens & Minor investor relations.